David Bullwinkle
Analyst · Ellington Management. Your line is open
Thanks, Jim, and good afternoon. Today, the Company filed its Form 10-K for the year ended December 31, 2018, with the Securities and Exchange Commission. As always, I recommend you to read this filing in its entirety. First, I would like to discuss the filing of the Company’s Form 12b-25, which extended the filing deadline for the Company’s Form 10-K. The Company and its senior management have been engaged in a review process to enable Jim to execute the Chief Executive Officer certifications required to be filed as exhibit to the Form 10-K. In addition, the evaluation disclosure of aspects of the Company’s obligations under its credit agreements, all in the context of preparing to close the sale of FPD, and working to refinance the remaining first lien term loans resulted in the Company being unable to file the Form 10-K within the prescribed time period. As Jim mentioned, subject to the satisfaction of customary closing conditions, the Company expects to close on the sale of FPD as early as April 8, 2019 and intends to use the proceeds to repay over $300 million of the term loans outstanding under the Company’s first lien term credit agreement. The Company has also been engaged in negotiations to refinance the portion of the first lien term loans that will not be paid from proceeds from the sale of FPD. I will now share further details on the full Company results, operational EBITDA and cash flow results for 2018. Please note, the results of FPD have been reported as discontinued operations in 2018 and the comparable 2017 period due to the expected sale of division, which will be completed soon. On slide four, as we reported in our earnings release, our financial results were a net loss of $16 million for 2018 compared to net income of $94 million in 2017. The 2018 results included benefit of $16 million related to the Korean withholding tax refund and $11 million associated with non-cash changes in workers’ compensation and legal reserves. The 2018 results also include expense of $13 million related to a trade name impairment, driven by the expected sale of FPD. The 2017 results include a benefit of $101 million associated with the release of evaluation allowance on deferred tax assets outside the U.S. The 2017 results also include $58 million of expense related to goodwill and trade name impairments, $47 million of income related to changes in value for the derivative embedded in the Series A preferred stock and $12 million of depreciation and amortization expense related to PROSPER asset remeasurement. Excluding these current and prior items, the loss for 2018 was $30 million compared to income of $16 million in the prior year. Turning to slide five. For 2018, we reported revenues of $1.325 billion, compared to $1.386 billion in 2017 for a decline of 4%. On a constant currency basis, revenue declined by 6%. Operational EBITDA for 2018 was $1 million, compared to $10 million in 2017. Excluding the unfavorable impact of foreign exchange and aluminum costs offset by the favorable impact of a reduction in workers’ compensation reserves, operational EBITDA improved to $21 million, compared to $10 million in the prior year. Adjusted operational EBITDA for 2018 after the expected declines of Consumer Inkjet were $16 million, compared to a loss of $1 million in 2017. In 2018, we delivered strong performance in our key growth engines. Volumes for SONORA Process Free Plates grew by 19% and the annuity revenue for PROSPER grew by 8%. We also continued to invest in future growth areas of ULTRASTREAM, light blocking materials and printed electronics. Moving on to the Company cash performance presented on slide six. The Company ended 2018 with $246 million in cash and cash equivalents, a decrease of $97 million from December 31, 2017. When adjusted for $14 million of proceeds from a non-recurring transaction expected to be received in December of 2018, but received in 2019 -- January 2019, our ending cash balance was within our expectations. During 2018, cash used in operating activities was $62 million, driven primarily by a change in working capital of $28 million and a decrease in liabilities excluding trade payables of $31 million. Cash used in investing activities was $22 million for 2018 as compared to the use of $24 million in the prior year period. Cash used in financing activities was $11 million for 2018, compared to a use of $29 million in the prior year period. Finally, as disclosed in our Form 10-K, we remain in compliance with our financial covenants under our credit agreements. In particular, the Company’s EBITDA used in the secured leverage ratio as calculated under the first lien term loan credit agreement exceeded the EBITDA necessary to satisfy the covenant ratio by $20 million. I will now turn the discussion back to Jim.